Autor(es): Bento, CM ; Calster, K ; Piller, T ; Oliveira, GS ; Vooght, L ; Cappoen, D ; Cos, P ; Gomes, MS ; Silva, T
Data: 2024
Identificador Persistente: https://hdl.handle.net/10216/165536
Origem: Repositório Aberto da Universidade do Porto
Autor(es): Bento, CM ; Calster, K ; Piller, T ; Oliveira, GS ; Vooght, L ; Cappoen, D ; Cos, P ; Gomes, MS ; Silva, T
Data: 2024
Identificador Persistente: https://hdl.handle.net/10216/165536
Origem: Repositório Aberto da Universidade do Porto
Mycobacterium abscessus (Mab) is an emerging pathogen that poses a severe health threat, especially in people with cystic fibrosis and other chronic lung diseases. Available drugs are largely ineffective due to an exquisite intrinsic resistance, making Mab infections only comparable to multidrug-resistant tuberculosis. Current treatment is based on lengthy multidrug therapy, complicated by poor outcomes and high rates of treatment failure, recurrence, and mortality. Thus, finding new and more efficient drugs to combat this pathogen is urgent. However, drug discovery efforts targeting Mab have been limited, and traditional drug screening methods are labor-intensive, low-throughput, and do not reflect clinical effectiveness. Therefore, this work aimed to develop a new, efficient, and reliable tool for drug screening against Mab that can be used in vitro for identifying hits in a high-throughput manner and in vivo to select drug candidates for future clinical trials. We engineered two stable double-reporter strains of Mab capable of emitting strong fluorescent and luminescent signals. This is due to the expression of mScarlet protein and luciferase enzyme or the entire lux operon. Importantly, these strains maintain the same ground characteristics as the non-transformed Mab strain. We show that these new strains can be applied to various setups, from MIC determination in broth cultures and macrophage infection assays to in vivo infection (using the Galleria mellonella model). Using these strains enhances the potential for high-throughput screening of thousands of compounds in a fast and reliable way.